Actively Recruiting
At-Home Neuromodulation for Female Sexual Dysfunction
Led by University of Michigan · Updated on 2025-12-23
24
Participants Needed
1
Research Sites
106 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot study investigates the regular use of non-invasive dorsal genital nerve stimulation (DGS) for the treatment of female sexual dysfunction (FSD). The researchers aim to determine whether subjects with FSD can correctly follow an at-home treatment regimen and to demonstrate that DGS can improve FSD arousal symptoms in premenopausal and postmenopausal women. Some subjects will use a smart vibrator for comparison to DGS.
CONDITIONS
Official Title
At-Home Neuromodulation for Female Sexual Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Capable of speaking and understanding English
- Able to comprehend the clinical study procedures and provide informed consent
- Diagnosed with female sexual dysfunction with a Female Sexual Function Index (FSFI) score of 26.55 or less and a score of 3 or less on lubrication, arousal, or orgasm subdomains
- Willing and able to follow the study protocol
- Able to attend experimental sessions at Michigan Medicine at the start and end of the study
You will not qualify if you...
- Not currently sexually active
- Pregnant or planning pregnancy during the study period
- History of neurological disorders or impairments affecting pelvic organ function, including dorsal genital nerve damage or lower motor dysfunction
- Implanted neurostimulator for bladder or bowel function
- Skin conditions causing sensitivity to stimulation electrodes
- Female sexual dysfunction limited only to low desire without lubrication, arousal, or orgasm issues
- Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic symptoms; or a score of 8 or higher on the American Urological Association Symptom Index
- Unable or unwilling to follow the study protocol
- Participating in another research study that could affect results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
Y
Yike Liu
CONTACT
T
Tim Bruns, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here